Jeanne Adiwinata Pawitan
Overview
Explore the profile of Jeanne Adiwinata Pawitan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdullah M, Pawitan J, Irawan C, - R, Aditianingsih D, Liem I, et al.
F1000Res
. 2025 Feb;
11:143.
PMID: 39931658
: Patients with severe COVID-19 had a higher increase in pro-inflammatory and anti-inflammatory cytokines than patients with moderate COVID-19. Excessive release of cytokine and chemokines can lead to multi-organ failure,...
2.
Kurniawan A, Dilogo I, Pawitan J, Widodo W, Oesman I, Martinus A
PLoS One
. 2024 Dec;
19(12):e0310467.
PMID: 39739689
Background And Purpose: Current treatments for peripheral nerve defects are suboptimal. Mesenchymal stem cell (MSC) implantation holds promise, with studies indicating their efficacy through the secretome. This study aims to...
3.
Anurogo D, Chen C, Lin C, Pawitan J, Qiu D, Qiu J
J Immunotoxicol
. 2024 Sep;
21(1):2400624.
PMID: 39319829
Infections caused by the influenza virus lead to both epidemic and pandemic outbreaks in humans and animals. Owing to their rapid production, safety, and stability, DNA vaccines represent a promising...
4.
Septiana W, Ayudyasari W, Gunardi H, Pawitan J, Balachander G, Yu H, et al.
In Vitro Cell Dev Biol Anim
. 2023 Dec;
59(10):747-763.
PMID: 38110841
The present study aimed to develop viable liver organoids using decellularized native liver scaffolds and evaluate the efficacy of human liver organoid transplantation in a rabbit model of cirrhosis. Liver...
5.
Ariesta Shinta Dewi P, Sitompul R, Pawitan J, Naroeni A, Dewayani Antarianto R
Int J Mol Cell Med
. 2023 Aug;
11(3):180-196.
PMID: 37605742
To investigate the efficacy of Wharton's jelly mesenchymal stem cells (WJSCs) and their conditioned medium (CM) for corneal nerve regeneration in rats with diabetic keratopathy. Streptozotocin (STZ)-induced male diabetic (DM)...
6.
Legiawati L, Suseno L, Sitohang I, Yusharyahya S, Pawitan J, Liem I, et al.
Stem Cell Res Ther
. 2023 Aug;
14(1):210.
PMID: 37605227
Introduction: Treatments for AGA have yet to produce satisfactory outcomes and may cause intolerable side effects. Recent studies have reported that adipose tissue-derived stem cell conditioned media (ADSC-CM) could induce...
7.
Lubis A, Aprianto P, Pawitan J, Priosoeryanto B, Dewi T, Kamal A
Acta Orthop
. 2023 Jun;
94:300-306.
PMID: 37377012
Background And Purpose: Mesenchymal stem cells (MSCs), both endogenous and exogenous, enhance chondrocyte proliferation by stimulating collagen type II. Secretome, an MSC derivate, has shown to also provide this mechanism...
8.
Sirait S, Bramono K, Menaldi S, Pawitan J, Indriatmi W, Aninditha T
PLoS Negl Trop Dis
. 2023 Jan;
17(1):e0010994.
PMID: 36595533
Background: Adipose derived stromal vascular fraction (SVF) contains a heterogeneous population of mononuclear cells, progenitor cells and about 1-10% are mesenchymal stromal cells. These cells are an ideal candidate for...
9.
Antarianto R, Mahmood A, Giselvania A, Asri Dewi A, Gustinanda J, Pawitan J
J Mol Histol
. 2022 Jul;
53(4):611-621.
PMID: 35882727
End-stage liver disease (ESLD) is a term used clinically in reference to a group of liver diseases with liver transplantation as the choice of treatment. Due to the limitations of...
10.
Rhatomy S, Pawitan J, Kurniawati T, Fiolin J, Dilogo I
Eur J Orthop Surg Traumatol
. 2022 Jun;
33(3):669-675.
PMID: 35699826
Background: Outcomes of the current management of posterior cruciate ligament (PCL) rupture are still unsatisfactory. Recent literature demonstrated the efficacy of the paracrine action of mesenchymal stem cells (MSC) in...